News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dicerna Pharmaceuticals (DRNA) Announces Participation In Panel On RNAi Therapeutics At 16th Annual Biotechnology Industry Organization (BIO) CEO And Investor Conference On February 10th


2/5/2014 8:08:09 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNAi-based therapeutics, today announced its participation in a panel discussion on RNAi therapeutics at the 16th Annual BIO CEO & Investor Conference. Douglas M. Fambrough, PhD, the company’s President and CEO, is scheduled to take part in a Therapeutic Workshop entitled: “Delivering the [RNAi] Goods” to be held on Monday, February 10th, at 10:30 a.m. Eastern Standard Time.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES